Chronic News and Research

RSS

New chemical compound to treat brain damage from stroke

Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke. The compound binds 1,000 times more effectively to the target protein in the brain than the potential drug currently being tested on stroke victims.

22 Feb 2012

Short telomeres may increase risk of chronic diseases

The ability to anticipate future events allows us to plan and exert control over our lives, but it may also contribute to stress-related increased risk for the diseases of aging, according to a study by UCSF researchers.

22 Feb 2012

Telomeres - the indicators of aging - are highly susceptible to stress and depression

Stress has numerous detrimental effects on the human body. Many of these effects are acutely felt by the sufferer, but many more go 'unseen', one of which is shortening of telomere length.

22 Feb 2012

Cedars-Sinai scientist to study potential treatments for AD

A Cedars-Sinai research scientist has been awarded two national grants totaling more than $2.5 million, including a prestigious Research Project Grant from the National Institutes of Health to study potential treatments for Alzheimer's disease.

21 Feb 2012

First Edition: February 21, 2012

Today's health policy headlines include reports about how the Supreme Court's consideration of the health law could prolong the fight over the sweeping measure.

21 Feb 2012

Drug 'addicted' newborn the latest hysteria driven absurdity

The Florida Society of Pain Management Providers (www.Flspmp.org) feels it is vital to set the factual record straight in light of the mass deception used to foment a hysteria driven war on pain medications that now is threatening the health and welfare of Florida's chronic pain patients.

21 Feb 2012

Gene that destroys cancerous cells also causes ageing

The role of one of our genes which protects us from cancer but could also cause us to age will be explained in a lecture at the University of Leicester.

21 Feb 2012

New triple-therapies found cost-effective for chronic hepatitis C patients with advanced liver disease

A towering $60,000 bill, a year of fierce, flu-like symptoms and a running risk of depression are among the possible costs of two new hepatitis C treatments. But according to Stanford University health policy researchers, they might be worth it.

21 Feb 2012

Frailty test for elderly also helps measure transplant candidates

A simple, 10-minute bedside assessment conducted prior to surgery appears to be the best method yet for predicting which kidney transplant patients will do well with their new organs, new Johns Hopkins research suggests.

21 Feb 2012

Natural compound of Chilean avocado plant can combat resistant yellow staphylococci

Aggressive infections in hospitals are an increasing health problem worldwide. The development of bacterial resistance is alarming. Now a young Danish scientist has found a natural substance in a Chilean rainforest plant that effectively supports the effect of traditional treatment with antibiotics.

20 Feb 2012

Modified imatinib cancer drug prevents morphine tolerance in rats

By reformulating the common cancer drug imatinib (Gleevec), researchers have eliminated morphine tolerance in rats - an important step toward improving the effectiveness of chronic pain management in patients, according to researchers at The University of Texas MD Anderson Cancer Center.

20 Feb 2012

Protein fragments from yellow field pea seeds can lower blood pressure

There are lots of new ideas out there for giving you extra protection against chronic diseases through the food you eat. But many good ideas may never make it to market. Researchers at the University of Guelph, led by Brian McBride, have found a way to enrich milk with docosahexaeonic acid (DHA)-an essential nutrient that many people are lacking.

19 Feb 2012

Botox efficacy uncertain in treating migraine says NICE

Botox – used as an anti-wrinkle agent - is unlikely to be recommended for the treatment of chronic migraines on the NHS in England and Wales. According to the National Institute for Health and Clinical Excellence (NICE) draft guidelines there is insufficient evidence that it works.

18 Feb 2012

Remote controlled microchip successfully delivers drug in early clinical trial

Researchers have developed a new microchip implant device that can deliver bone-building drugs to seven osteoporosis patients. The microchips worked inside patients as drug-delivering pacemakers, following a prescription plan sent by radio signal.

18 Feb 2012

CVS Caremark's integrated businesses help patients achieve better health

CVS Caremark's chief health care strategy officer today outlined how the company's integrated offerings -- retail pharmacy, pharmacy benefit management (PBM) and retail clinics -- are helping patients achieve better health by working to increase medication adherence and targeting behaviors to improve treatment for chronic diseases.

18 Feb 2012

CCF endorses bill to identify students at risk of sudden cardiac death

Senators Frank R. Lautenberg (D-NJ) and Robert Menendez (D-NJ) introduced today during National Heart Month the Cardiomyopathy Health Education, Awareness, Risk Assessment and Training in the Schools (HEARTS) Act to the Senate.

18 Feb 2012

FDA to reconsider diet drug that failed to get approval in 2010

Next week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The F.D.A. rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug's manufacturer is now presenting additional data to argue its case.

18 Feb 2012

MSF warns health, living conditions of refugees in Dadaab camp deteriorating

The medical aid group Medecins Sans Frontieres (MSF) on Thursday said the conditions for hundreds of thousands of refugees living in Kenya's Dadaab refugee camp are worsening and people there "are experiencing a 'humanitarian emergency' because of the scaling back of aid work," Deutsche Presse-Agentur/M&C reports (2/16).

18 Feb 2012

ACAAI allergists available to discuss risks associated with asthma

The tragic death of journalist Anthony Shadid due to asthma and allergies underscores the realities of these serious diseases. Allergists Stanley Fineman, MD, president of the American College of Allergy, Asthma and Immunology, (ACAAI), and James Sublett, MD, chair of the ACAAI Environment Committee are available to discuss the risks associated with asthma.

18 Feb 2012

Patient Services to join National Organization for Rare Disorders

Patient Services, Inc. will join the National Organization for Rare Disorders (NORD) and others around the world in observing Rare Disease Day on February 29. The purpose is to focus attention on the needs of patients and families affected by rare diseases.

18 Feb 2012